1. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants 
Roland Kaufmann, MD, Regina Fölster-Holst, MD, Peter Höger, MD, Diamant Thaçi, MD, Helena Löffler, MD, Doris Staab, MD, Matthias Bräutigam, PhD 
Journal of Allergy and Clinical Immunology 
Volume 114, Issue 5, Pages (November 2004)
DOI: /j.jaci
Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

2. Fig 1
Improvement in clinical symptoms of atopic eczema as assessed by EASI score during the double-blind and open-label phases.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

3. Fig 2
Improvement in clinical symptoms of atopic eczema in patients treated with pimecrolimus cream 1% during the double-blind phase. Mean total EASI score in patients with mild or moderate disease (IGA=2-3; A) compared with that seen in patients with severe or very severe disease (IGA=4-5; B).
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

4. Fig 3
Percentage of patients with an improvement of at least 50% from baseline according to the primary caregiver's assessment (visual analog scale). A, Pruritus. B, Sleep loss.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions